Corteva, Inc. reported revenue of $6.38B for the period ended 2026-06-30, -1.2% year on year. Net income was $1.16B, a 18.2% net margin on a 57.4% gross margin. The largest revenue line is Seed at 71% of the total. Free cash flow for the period was $-3.56B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $6.38B | -1.2% |
| Gross profit | $3.66B | — |
| Operating income | $2.11B | — |
| Net income | $1.16B | -11.6% |
| Gross margin | 57.4% | Net margin 18.2% |
| Revenue Q/Q | +30.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| Seed | $4.53B | 71.0% |
| Crop Protection | $1.85B | 29.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.72B | 42.6% |
| R&D | $0.39B | 6.1% |
| SG&A | $1.16B | 18.2% |
| Tax & other | $0.95B | 14.9% |
| Item | Amount |
|---|---|
| Total assets | $41.64B |
| Total liabilities | $16.24B |
| Shareholders' equity | $25.40B |
| Equity / assets | 61.0% |
| Operating cash flow | $-3.36B |
| Capital expenditure | $0.20B |
| Free cash flow | $-3.56B |
| Cash conversion (OCF / net income) | -40% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CSGP ・ COST ・ CRH ・ CRWD ・ CCI ・ CSX ・ CMI ・ CVS ・ DHR ・ DRI ・ DDOG ・ DVA
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies